Molecular strategies for the electrophysiologist
Luca Boveri and Silvia G Priori
This article has no abstract so we have provided the first paragraph of the full text.
Since the release of results from the Cardiac Arrhythmia Suppression Trial (CAST), trust in pharmacological prevention of sudden cardiac death has progressively reduced. The search for approaches alternative to antiarrhythmic agents for the prevention of ventricular arrhythmias has led to the current situation in which catheter ablation and the implantation of defibrillators are the leading tools of the arrhythmia specialist.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
From catheters to vectors: the dawn of molecular electrophysiologyNature Medicine News and Views (01 Dec 2000)
Listening for hoof beats in heart beatsNature Medicine News and Views (01 Sep 2000)
On the pulse of genetic cardiologyNature Genetics News and Views (01 Oct 1994)
